Michelle Lenarduzzi
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 1
- RNA Research and Splicing 1
- Co-authors
- Fei‐Fei Liu (6 shared papers)Angela Bik‐Yu Hui (5 shared papers)Brian O’Sullivan (4 shared papers)Wei Shi (5 shared papers)John Waldron (3 shared papers)Nehad M. Alajez (4 shared papers)Shi‐Jun Yue (4 shared papers)Jeff Bruce (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)PLoS ONE (2 papers)Cancer Research (1 paper)Cell Death and Disease (1 paper)Oncotarget (1 paper)
- Partner nations
- CanadaSaudi Arabia
In The Last Decade
Michelle Lenarduzzi
7 papers receiving 877 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 574
- Molecular Biology 575
- Otorhinolaryngology 21
- Oncology 67
- Genetics 14
Countries citing papers authored by Michelle Lenarduzzi
This map shows the geographic impact of Michelle Lenarduzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lenarduzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lenarduzzi more than expected).
Fields of papers citing papers by Michelle Lenarduzzi
This network shows the impact of papers produced by Michelle Lenarduzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lenarduzzi. The network helps show where Michelle Lenarduzzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Lenarduzzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 324 | |
| 2 | 2011 | 243 | |
| 3 | 2010 | 125 | |
| 4 | 2012 | 76 | |
| 5 | 2013 | 53 | |
| 6 | 2009 | 51 | |
| 7 | 2013 | 18 |
About Michelle Lenarduzzi
Michelle Lenarduzzi is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Materials Chemistry, having authored 7 papers that have together received 890 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), Sarcoma Diagnosis and Treatment (1 paper), MXene and MAX Phase Materials (1 paper), Epigenetics and DNA Methylation (1 paper), RNA Research and Splicing (1 paper) and Iron Metabolism and Disorders (1 paper). The work is most often cited by research in Cancer Research (574 citations), Molecular Biology (575 citations), Otorhinolaryngology (21 citations), Oncology (67 citations) and Genetics (14 citations). Michelle Lenarduzzi has collaborated with scholars based in Canada and Saudi Arabia. Frequent co-authors include Fei‐Fei Liu, Angela Bik‐Yu Hui, Brian O’Sullivan, Wei Shi, John Waldron, Nehad M. Alajez, Shi‐Jun Yue, Jeff Bruce, Melania Pintilie and Igor Jurišica. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Cancer Research, Cell Death and Disease and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.